Sunday, January 29, 2017
Category: Antimicrobial Stewardship, Mould Infections, Pulmonary Infections, Transplant Infectious Diseases
Dr. Rod Quilitz, ID clinical pharmacist and Moffitt Cancer Center and Research Institute, discusses the Moffitt approach to the identification, assessment, and management of invasive fungal infections in the immunocompromised host.
Stay in touch! Download our app in the iTunes store or the Google Marketplace.